Shelter Mutual Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Hold
27,600
2.9% 11
2026
Q1
$12.3M Hold
27,600
2.74% 12
2025
Q4
$12.5M Hold
27,600
2.79% 12
2025
Q3
$10.8M Hold
27,600
2.42% 15
2025
Q2
$12.3M Hold
27,600
2.85% 13
2025
Q1
$13.4M Hold
27,600
3.23% 6
2024
Q4
$11.1M Hold
27,600
2.77% 11
2024
Q3
$13.9M Hold
27,600
3.31% 6
2024
Q2
$12.9M Hold
27,600
3.37% 4
2024
Q1
$11.5M Hold
27,600
2.97% 6
2023
Q4
$11.2M Hold
27,600
3.1% 5
2023
Q3
$9.6M Sell
27,600
-4,800
-15% -$1.68M 2.68% 12
2023
Q2
$11.4M Sell
32,400
-10,900
-25% -$3.67M 2.77% 10
2023
Q1
$13.6M Hold
43,300
3.8% 5
2022
Q4
$12.5M Hold
43,300
3.59% 4
2022
Q3
$12.5M Hold
43,300
4.06% 3
2022
Q2
$12.2M Hold
43,300
3.7% 3
2022
Q1
$11.3M Hold
43,300
2.96% 13
2021
Q4
$9.51M Hold
43,300
2.47% 18
2021
Q3
$7.85M Hold
43,300
2.21% 20
2021
Q2
$8.73M Hold
43,300
2.44% 18
2021
Q1
$9.3M Buy
+43,300
New +$9.51M 2.61% 15

Other funds holding VRTX

Shelter Mutual Insurance's VRTX Position: Q2 2026 in Review

Shelter Mutual Insurance held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 27,600 shares worth $13.7M. The position accounts for 2.9% of the portfolio, ranked #11.

Shelter Mutual Insurance first reported a position in VRTX in Q1 2021 and has held it in 22 quarters since. The position peaked at $13.9M in Q3 2024. 1,744 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Shelter Mutual Insurance held 27,600 shares of Vertex Pharmaceuticals worth $13.7M as of Q2 2026.
  • Shelter Mutual Insurance left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 2.9% of Shelter Mutual Insurance's portfolio in Q2 2026, its #11 holding.
  • Shelter Mutual Insurance first reported a position in Vertex Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
  • Shelter Mutual Insurance's Vertex Pharmaceuticals position peaked at $13.9M in Q3 2024.
  • 1,744 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Shelter Mutual Insurance's 13F filing for Q2 2026, filed 11 Aug 2026.